Striatal neuropeptide levels in Parkinson's disease patients
- 1 October 1992
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 145 (2) , 171-174
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Isocratic reverse-phase HPLC separation and RIA used in the analysis of neuropeptides in brain tissueNeuropeptides, 1991
- Met-enkephalin immunoreactivity in the basal ganglia in symptomatic and asymptomatic MPTP-exposed monkeys: correlation with degree of parkinsonian symptomsNeuroscience Letters, 1991
- Met‐enkephalin immunoreactivity in the basal ganglia in Parkinson's disease and striatonigral degenerationNeurology, 1990
- Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's DiseaseJournal of Neurochemistry, 1989
- Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervationExperimental Brain Research, 1989
- Neonatal and Adult 6‐Hydroxydopamine‐Induced Lesions Differentially Alter Tachykinin and Enkephalin Gene ExpressionJournal of Neurochemistry, 1987
- Peptides and Parkinson's diseaseTrends in Neurosciences, 1985
- Immunocytochemical Studies of Substance P and Met-Enkephalin in the Basal Ganglia and Substantia Nigra in Huntingtonʼs, Parkinsonʼs and Alzheimerʼs DiseasesJournal of Neuropathology & Experimental Neurology, 1985
- Enkephalinergic Markers in Substantia Nigra and Caudate Nucleus from Parkinsonian SubjectsJournal of Neurochemistry, 1984
- Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brainsBrain Research, 1983